Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ghisoni, F."" wg kryterium: Autor


Tytuł :
LBA49 - palliative care Evaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial
Autorzy :
Franciosi, V.
Pokaż więcej
Źródło :
In Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark, Annals of Oncology 1 October 2016 27 Supplement 6:vi584-vi584
Czasopismo naukowe
Tytuł :
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial.
Autorzy :
Meessen JMTA; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Cardinale D; Cardioncology Unit, European Institute of Oncology, Milan, Italy.
Ciceri F; Haematology/Transplant Unit, IRCCS Ospedale San Raffaele, Università Vita-Salute, Milan, Italy.
Sandri MT; Laboratory Medicine, Humanitas Clinical and Reseach Center - IRCCS - Rozzano, Milan, Italy.
Civelli M; Department of Cardiology, European Institute of Oncology, Milan, Italy.
Bottazzi B; Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
Cucchi G; Department of Cardiology, Ospedale di Sondrio, Sondrio, Italy.
Menatti E; Department of Oncology, Ospedale di Sondrio, Sondrio, Italy.
Mangiavacchi M; Department of Cardiology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
Condorelli G; Department of Cardiology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
Barbieri E; Department of Cardiology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
Gori S; Department of Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
Colombo A; Cardioncology Unit, European Institute of Oncology, Milan, Italy.
Curigliano G; Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology, Milan, Italy.
Salvatici M; Laboratory Medicine, Humanitas Clinical and Reseach Center - IRCCS - Rozzano, Milan, Italy.
Pastori P; Department of Cardiology, Ospedale di Vaio, Fidenza, Italy.
Ghisoni F; Unità Operativa Complessa Cure Palliative, Ospedale di Vaio, Fidenza, Italy.
Bianchi A; Department of Cardiology, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
Falci C; Department of Oncology, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
Cortesi P; Department of Cardiology, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, Meldola, Italy.
Farolfi A; Department of Oncology, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, Meldola, Italy.
Monopoli A; Department of Cardiology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
Milandri C; Department of Oncology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
Bregni M; Department of Oncology, Presidio Ospedaliero di Busto Arsizio, Busto Arsizio, Italy.
Malossi A; Department of Oncology, Ospedale Regionale Umberto Parini, Aosta, Italy.
Nassiacos D; Department of Cardiology, Presidio Ospedaliero di Saronno, Saronno, Italy.
Verusio C; Department of Oncology, Presidio Ospedaliero di Saronno, Saronno, Italy.
Staszewsky L; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Leone R; Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
Novelli D; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Balconi G; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Nicolis EB; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Franzosi MG; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Masson S; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Garlanda C; Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.; Humanitas University, Milan, Italy.
Mantovani A; Department of Immunology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.; Humanitas University, Milan, Italy.; The William Harvey Research Institute, Queen Mary University of London, London, UK.
Cipolla CM; Department of Cardiology, European Institute of Oncology, Milan, Italy.
Latini R; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Pokaż więcej
Corporate Authors :
ICOS-ONE Study Investigators
Źródło :
ESC heart failure [ESC Heart Fail] 2020 Aug; Vol. 7 (4), pp. 1452-1466. Date of Electronic Publication: 2020 May 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial.
Autorzy :
Franciosi V; Medical Oncology Unit, University Hospital, Parma, Italy. .
Maglietta G; Research and Innovation Unit, University Hospital, Parma, Italy.
Degli Esposti C; Medical Oncology Unit, University Hospital, Bologna, Italy.
Caruso G; Medical Oncology Unit, University Hospital, Parma, Italy.
Cavanna L; Medical Oncology Unit, General Hospital, Piacenza, Italy.
Bertè R; Palliative Care Unit, General Hospital, Piacenza, Italy.
Bacchini G; Medical Oncology Unit, University Hospital, Parma, Italy.
Bocchi L; Medical Oncology Unit, University Hospital, Parma, Italy.
Piva E; Medical Oncology Unit, University Hospital, Ferrara, Italy.
Monfredo M; Medical Oncology Unit, General Hospital, Piacenza, Italy.
Scafuri V; Medical Oncology Unit, University Hospital, Ferrara, Italy.
Di Cesare P; Medical Oncology Unit, General Hospital, Piacenza, Italy.
Melotti B; Medical Oncology Unit, University Hospital, Bologna, Italy.
Sequino M; Research and Innovation Unit, University Hospital, Parma, Italy.
Rimanti A; Medical Oncology Unit, University Hospital, Parma, Italy.
Binovi C; Medical Oncology Unit, University Hospital, Parma, Italy.
Ghisoni F; Palliative Care Unit, General Hospital, Fidenza, Italy.
Caminiti C; Research and Innovation Unit, University Hospital, Parma, Italy.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2019 Sep; Vol. 8 (4), pp. 381-389. Date of Electronic Publication: 2019 Mar 14.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial
MeSH Terms :
Biliary Tract Neoplasms/*psychology
Carcinoma, Non-Small-Cell Lung/*psychology
Lung Neoplasms/*psychology
Palliative Care/*psychology
Pancreatic Neoplasms/*psychology
Stomach Neoplasms/*psychology
Biliary Tract Neoplasms/therapy ; Carcinoma, Non-Small-Cell Lung/therapy ; Female ; Humans ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Pancreatic Neoplasms/therapy ; Prospective Studies ; Quality of Life ; Stomach Neoplasms/therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.
Autorzy :
Cardinale D; Cardioncology Unit, European Institute of Oncology, Milano, Italy.
Ciceri F; Haematology/Transplant Unit, Istituto Scientifico H. San Raffaele, Milano, Italy.
Latini R; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy. Electronic address: .
Franzosi MG; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Sandri MT; Laboratory Medicine Division, European Institute of Oncology, Milano, Italy.
Civelli M; Cardioncology Division, European Institute of Oncology, Milano, Italy.
Cucchi G; Cardiology, Ospedale di Sondrio, Italy.
Menatti E; Oncology, Ospedale di Sondrio, Italy.
Mangiavacchi M; Cardiology, Istituto Clinico Humanitas, Rozzano, Italy.
Cavina R; Oncology, Istituto Clinico Humanitas, Rozzano, Italy.
Barbieri E; Cardiology, Ospedale Sacro Cuore, Negrar, Italy.
Gori S; Oncology, Ospedale Sacro Cuore, Negrar, Italy.
Colombo A; Cardioncology Unit, European Institute of Oncology, Milano, Italy.
Curigliano G; Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology, Milano, Italy.
Salvatici M; Laboratory Medicine Division, European Institute of Oncology, Milano, Italy.
Rizzo A; Cardiology, Ospedale di Vaio, Fidenza, Italy.
Ghisoni F; Unità Operativa Complessa Cure Palliative, Ospedale di Vaio, Fidenza, Italy.
Bianchi A; Cardiology, Istituto Oncologico Veneto, Padova, Italy.
Falci C; Oncology, Istituto Oncologico Veneto, Padova, Italy.
Aquilina M; Cardiology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRCCS, Meldola, Italy.
Rocca A; Oncology, IRCCS-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
Monopoli A; Cardiology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
Milandri C; Oncology, Nuovo Ospedale San Giuseppe, Empoli, Italy.
Rossetti G; Cardiology, Presidio Ospedaliero di Busto Arsizio, Italy.
Bregni M; Oncology, Presidio Ospedaliero di Busto Arsizio, Italy.
Sicuro M; Cardiology, Ospedale Regionale Umberto Parini, Aosta, Italy.
Malossi A; Oncology, Ospedale Regionale Umberto Parini, Aosta, Italy.
Nassiacos D; Cardiology, Presidio Ospedaliero di Saronno, Saronno, Italy.
Verusio C; Oncology, Presidio Ospedaliero di Saronno, Saronno, Italy.
Giordano M; Oncology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy.
Staszewsky L; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Barlera S; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Nicolis EB; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Magnoli M; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Masson S; Department of Cardiovascular Research, IRCCS - Mario Negri Institute for Pharmacological Research, Milano, Italy.
Cipolla CM; Cardioncology Division, European Institute of Oncology, Milano, Italy.
Pokaż więcej
Corporate Authors :
ICOS-ONE Study Investigators
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 May; Vol. 94, pp. 126-137. Date of Electronic Publication: 2018 Mar 20.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Antineoplastic Agents/*adverse effects
Enalapril/*therapeutic use
Troponin C/*blood
Ventricular Dysfunction, Left/*prevention & control
Adult ; Aged ; Anthracyclines/adverse effects ; Cardiotoxicity/blood ; Cardiotoxicity/prevention & control ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/drug therapy ; Ventricular Dysfunction, Left/blood ; Ventricular Dysfunction, Left/chemically induced
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies